Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 20, 2025, titled "Senores Pharmaceuticals acquires ANDA for Roflumilast 250 mcg and 500 mcg tablets".
Press Release Feb 20 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Senores Pharmaceuticals Ltd. on 6ix
Earlier from Senores Pharmaceuticals
Later from Senores Pharmaceuticals
- Press Release Feb 26 2025
- Press Release Mar 04 2025
- Press Release May 05 2025
- Senores Pharmaceuticals Ltd. Press Release May 09 2025
- Press Release May 15 2025
Follow Senores Pharmaceuticals into a list and get an email when it puts out news.
Follow Senores Pharmaceuticals